Director’s Corner A diagnosis of cancer is never easy, but to face it cancer. Following surgery at Robert Wood Johnson University Hospital, an RWJBarnabas Health facility, the 90-minute trip each way for chemotherapy treatment was not practical, so our team worked with colleagues at Community Medical Center in Toms River, an RWJBarnabas Health facility, to ensure he received the care he needed, when he needed it (page 19). Our broad reach not only focuses on treatment but prevention and research as well. Thanks to efforts by Rutgers Cancer Institute of New Jersey at University Hospital, those in the Newark and greater essex County region will have access to free breast and cervical cancer screenings through a ‘See, Test and Treat’ event this fall (page 23). And thanks to supporters like the Val Skinner Foundation and those who give toward the annual ‘Century for the Cure’ bike ride, Middlesex County Pancreatic Cancer 5K Walk/Run and numerous golf outings, we are able to help explore new avenues in cancer research and treatment. Rutgers Cancer Institute together with RWJBarnabas Health represents a broad constellation across our state. While each location shines in its own way, we are committed to collaborating with one another to ensure the residents of New Jersey and beyond are receiving world class care close to home. Sincerely, versity and RWJBarnabas Health understand that. That understanding is evident in a recently announced letter of intent between Rutgers University and RWJBarnabas Health to create a premier academic health care system – one that is dedicated to leading-edge research and world class health and medical education. But most important, this new venture will provide high-quality patient care that will transform and advance health care in our state including oncology care. It is why we continue to focus on the delivery of integrated cancer care between Rutgers Cancer Institute and the 11 RWJBarnabas Health facilities across the state through our expanded partnership. For example, if a patient is eligible for a clinical trial or other treatment offered in New Brunswick but they live far away, we’ll explore how that therapy may be administered closer to home. Conversely, our community partners know that when their patient needs the comprehensive offerings that a National Cancer Institute-designated cancer center can provide, they know we’re here and ready to help. Our cover story of Sandrine Holloway-Davis, who had a rare virus hardly seen in the United States, illustrates this. Upon realizing a diagnosis of HTLV-1, doctors at Monmouth Medical Center, an RWJBarnabas Health facility, recommended Rutgers Cancer Institute as one of the few places in the tri-state area that could manage the unique treatment and bone marrow transplant that was required for her resulting lymphoma (page 8). Postal carrier Patrick Keeley was enjoying work and his Ocean County dream home with his fiancée when he was diagnosed with esophageal Steven K. Libutti, MD, FACS Director, Rutgers Cancer Institute of New Jersey Vice Chancellor, Cancer Programs, Rutgers Biomedical and Health Sciences Senior Vice President, Oncology Services, RWJBarnabas Health J O H N O ’ B Oy L e alone can be more than a challenge. We at Rutgers Cancer Institute of New Jersey, Rutgers Uni- Richard Drachtman, MD Interim Chief, Pediatric Hematology/Oncology Steven K. Libutti, MD, FACS Director Vice Chancellor, Cancer Programs, RBHS and Senior Vice President, Oncology Services, RWJBarnabas Health David A. August, MD Interim Chief, Surgical Oncology Joseph R. Bertino, MD Senior Scientific Advisor to the Director Kevin Coyle Chief Financial Officer Shabbar Danish, MD Chief, Neurosurgical Oncology David J. Foran, PhD Chief Informatics Officer and Executive Director, Biomedical Informatics Shridar Ganesan, MD, PhD Associate Director for Translational Science and Chief, Molecular Oncology Susan Goodin, PharmD Executive Director, Statewide Affairs Bruce G. Haffty, MD Chief of Staff and Chair, Radiation Oncology Isaac Yi Kim, MD, PhD Chief, Urologic Oncology Amanda M. Laird, MD, FACS Chief, Endocrine Surgery Edmund C. Lattime, PhD Associate Director for Education and Training Sharon Manne, PhD Associate Director for Cancer Prevention, Control and Population Science Janice Mehnert, MD Director, Phase I and Investigational Therapeutics Lorna Rodriguez, MD, PhD Director, Precision Medicine and Interim Chief, Gynecologic Oncology Roger Strair, MD, PhD Division Chief, Blood Disorders Antoinette M. Stroup, PhD Director, New Jersey State Cancer Registry Linda Tanzer Chief Administrative and Operating Officer and Associate Director for Administration and Planning Deborah L. Toppmeyer, MD Chief Medical Officer and Chief, Solid Tumor Oncology Eileen White, PhD Deputy Director, Chief Scientific Officer and Associate Director for Basic Science Steven Zheng, PhD Division Chief, Cancer Pharmacology